Corning Offers 3D Cell Culture and Scale-Up Solutions at SLAS 2017

We use cookies to ensure the best experience on our website.
View Cookie Policy
/worldwide/en/corning-cookie-policy.html
_self
Accept Cookie Policy
Change My Settings
ESSENTIAL COOKIES
Required for the site to function.
PREFERENCE AND ANALYTICS COOKIES
Augment your site experience.
SOCIAL AND MARKETING COOKIES
Lets Corning work with partners to enable social features and marketing messages.
ALWAYS ON
ON
OFF

This site is best viewed in a modern web browser. Please update your browser for the best experience possible.

Close[x]
news release

Corning Offers 3D Cell Culture and Scale-Up Solutions at SLAS 2017

Corning Offers Scale-Up Solutions at SLAS 2017

News Releases
CLS
Corning Offers 3D Cell Culture and Scale-Up Solutions at SLAS 2017
Corning Offers 3D Cell Culture and Scale-Up Solutions at SLAS 2017
CORNING, N.Y. | Corning Incorporated | January 17, 2017
Corning Life Sciences showcases diverse and growing portfolio

Corning Incorporated (NYSE: GLW) will showcase its latest drug discovery solutions, with a focus on 3D cell culture and products for high-throughput screening of 3D spheroids at the Society for Laboratory Automation & Screening (SLAS) 2017 Conference, Feb. 4-8 in Washington, D.C.

Corning will feature an array of its life sciences solutions in Booth 1337, in the Walter E. Washington Convention Center, including:

  • 3D cell culture (including organoid and spheroid applications)
  • High-throughput screening (including 3D)
  • Cancer research applications
  • Sample handling and cryopreservation
  • ADME/toxicology

“We will show visitors how Corning products can help customers utilize the exciting potential of 3D cell culture,” said Richard Eglen, Ph.D., vice president and general manager, Corning Life Sciences. “We believe that helping our customers make the transition from 2D to 3D, whether for a target discovery, lead identification and optimization, or in high-throughput screening, will greatly accelerate drug discovery.”

An exhibitor tutorial session, entitled “3-Dimensional Cell Culture Systems, Novel Technologies, and Their Use at the Laboratory Bench,” will be co-hosted by Corning Life Sciences and Scripps Research Institute at 9:30 a.m. Tuesday, Feb. 7, in Room 150A in the convention center.

“The benefits of 3D cell culture are becoming well-known in the pharmaceutical industry, but customers are still looking for guidance and further innovations as they transition from 2D culture,” said Keith R. Olson, Ph.D., global director, CLS Business Operations. “Corning has been an established leader in the 3D field for over 25 years, providing solutions that range from surfaces such as Corning® Matrigel® matrix, to systems such as Transwell® plates, and now to our new spheroid microplates for HTS. Our products, partnerships, and scientific support capabilities provide the tools researchers need to navigate the exciting new applications in this field.”

After serving a three-year term on the SLAS Board of Directors and last year as its president, Dr. Eglen will step down from the board this year. He was elected to the SLAS board in 2014 in recognition of his achievements in the life sciences industry and significant contributions to the global SLAS community.

Dr. Eglen will be available for interviews throughout the week to discuss Corning’s latest innovations. To schedule an interview, contact Elizabeth Fryman at (978) 684-2659; or email at: frymane@corning.com.

Corning Life Sciences brings new and innovative laboratory technologies to researchers worldwide and helps customers succeed by providing innovative, high-quality products and services in the areas of polymer science, biochemistry and molecular biology, glass melting and forming, surface modification, and characterization science.

To learn more about Corning Life Sciences products, contact a customer service representative at (800) 492-1110; outside the United States, call (978) 442-2200; or visit www.corning.com/lifesciences. To learn more about Corning’s 3D cell culture products, please visit http://www.corning.com/worldwide/en/products/life-sciences/news-events/events/2017/02/slas-2017.html.

Forward-Looking and Cautionary Statements

This press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.

Digital Media Disclosure

In accordance with guidance provided by the SEC regarding the use of company websites and social media channels to disclose material information, Corning Incorporated (“Corning”) wishes to notify investors, media, and other interested parties that it intends to use its website (http://www.corning.com/worldwide/en/about-us/news-events.html) to publish important information about the company, including information that may be deemed material to investors. The list of websites and social media channels that the company uses may be updated on Corning’s media and website from time to time. Corning encourages investors, media, and other interested parties to review the information Corning may publish through its website and social media channels as described above, in addition to the company’s SEC filings, press releases, conference calls, and webcasts.

About Corning Incorporated

Corning (www.corning.com) is one of the world’s leading innovators in materials science. For more than 160 years, Corning has applied its unparalleled expertise in specialty glass, ceramics, and optical physics to develop products that have created new industries and transformed people’s lives. Corning succeeds through sustained investment in R&D, a unique combination of material and process innovation, and close collaboration with customers to solve tough technology challenges. Corning’s businesses and markets are constantly evolving. Today, Corning’s products enable diverse industries such as consumer electronics, telecommunications, transportation, and life sciences. They include damage-resistant cover glass for smartphones and tablets; precision glass for advanced displays; optical fiber, wireless technologies, and connectivity solutions for high-speed communications networks; trusted products that accelerate drug discovery and manufacturing; and emissions-control products for cars, trucks, and off-road vehicles.